Evidence map›Paper›PMID 41601972›Full record

ArticleFrontiers in pharmacology2025

The role of total polysaccharides from

Yachao Ren, Shenghua Hou, Guoyou Chen, Yulong Zhou

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yachao Ren *College of Animal Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, China.
Shenghua Hou *Harbin Medical University-Daqing, Daqing, China.
Guoyou Chen *Harbin Medical University-Daqing, Daqing, China.
Yulong ZhouCollege of Animal Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: C57BL/6 mice were randomly assigned to three groups: the negative control, model, and SAP treatment groups. The influence of SAP on ulcerative colitis (UC) was evaluated by water and food intake, body weight change, diarrhea, bloody stool, colon length, histological analysis, disease activity index, and immune parameters. The effects of SAP on the gut microbiota (GM) were investigated using 16S rRNA sequencing. The impact of SAP on metabolites was evaluated using non-targeted metabolomics analysis. Results: SAP attenuated colitis and modified immune parameters. 16S rRNA sequencing showed that the abundance of Conclusion: The protective effect of SAP on the model mice may be related to GM diversity and metabolites.

Indexed as

colitisgut microbiotanon-targeted metabolomics analysispolysaccharideSonchus arvensis L.

Identifiers

PMID41601972
PMCPMC12832633

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.